
Advice for the Patient Starting Treatment With Talquetamab
Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational materials, and understand that while initial side effects can be challenging, they are temporary and manageable with proper preparation and support.
Episodes in this series

Alan emphasizes the critical importance of maintaining a positive attitude throughout treatment, believing that cells respond better to positive mental states and that optimism contributes to treatment success. His advice centers on patience and persistence, acknowledging that while side effects can be challenging initially, they improve significantly over time. He stresses the temporary nature of most toxicities and the excellent quality of life achievable once the initial adjustment period passes.
Mary Kay's advice focuses on thorough preparation and knowledge acquisition, emphasizing that being informed about expected side effects makes the experience more manageable. She recommends asking questions, staying alert to patient changes, and maintaining detailed records of symptoms and side effects. Her philosophy centers on preparation reducing anxiety and improving the overall treatment experience for both patients and caregivers.
Both perspectives highlight the "wave-like" nature of talquetamab side effects, where multiple toxicities may appear simultaneously but resolve together over the first few months of treatment. Their combined advice emphasizes that surviving the initial side effect period leads to substantial improvements in quality of life, with Alan noting that patients eventually "feel like a normal person." The transition from bi-weekly to monthly dosing further improves the treatment experience as patients demonstrate disease response.
Newsletter
Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.


















































































